Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

Second report of clinical efficacy for rotavirus vaccine

Nov. 18, 1997

Novartis submits BLA for Simulect in U.S.

Nov. 17, 1997

Immunological method for preventing ALL in children available for licensing

Nov. 17, 1997

Peptide + ciclosporin combination improves renal allograft survival and function

Nov. 14, 1997

Anti-CD45 MAb prolongs islet xenograft survival in diabetic mice

Nov. 14, 1997

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

Nov. 12, 1997

LXR to commence pivotal trials with HK-Cardiosol

Nov. 10, 1997

Mechanism of action of triptolide investigated in human T-cells

Nov. 10, 1997

Confirmatory trials of Alpha-Beta's Betafectin to begin

Nov. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...